These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22683790)

  • 1. Structural basis for the autoinhibition of the C-terminal kinase domain of human RSK1.
    Li D; Fu TM; Nan J; Liu C; Li LF; Su XD
    Acta Crystallogr D Biol Crystallogr; 2012 Jun; 68(Pt 6):680-5. PubMed ID: 22683790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of MSK1 reveals a novel autoinhibitory conformation for a dual kinase protein.
    Smith KJ; Carter PS; Bridges A; Horrocks P; Lewis C; Pettman G; Clarke A; Brown M; Hughes J; Wilkinson M; Bax B; Reith A
    Structure; 2004 Jun; 12(6):1067-77. PubMed ID: 15274926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
    Roux PP; Richards SA; Blenis J
    Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.
    Mérienne K; Jacquot S; Zeniou M; Pannetier S; Sassone-Corsi P; Hanauer A
    Oncogene; 2000 Aug; 19(37):4221-9. PubMed ID: 10980595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
    Lee SJ; Kim SG
    Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of the N-terminal kinase domain of human RSK1 bound to three different ligands: Implications for the design of RSK1 specific inhibitors.
    Ikuta M; Kornienko M; Byrne N; Reid JC; Mizuarai S; Kotani H; Munshi SK
    Protein Sci; 2007 Dec; 16(12):2626-35. PubMed ID: 17965187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model.
    Li S; Zhou Y; Lu W; Zhong Y; Song W; Liu K; Huang J; Zhao Z; Xu Y; Liu X; Li H
    J Chem Inf Model; 2011 Nov; 51(11):2939-47. PubMed ID: 21995341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic control of RSK complexes by phosphoswitch-based regulation.
    Gógl G; Biri-Kovács B; Póti ÁL; Vadászi H; Szeder B; Bodor A; Schlosser G; Ács A; Turiák L; Buday L; Alexa A; Nyitray L; Reményi A
    FEBS J; 2018 Jan; 285(1):46-71. PubMed ID: 29083550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and inhibition of the C-terminal kinase domain of p90 ribosomal S6 kinases.
    Fruergaard MU; Nielsen CJF; Kjeldsen CR; Iversen L; Andersen JL; Nissen P
    Life Sci Alliance; 2023 May; 6(5):. PubMed ID: 36806093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration.
    Yang S; Ji M; Zhang L; Chen Y; Wennmann DO; Kremerskothen J; Dong J
    Cell Signal; 2014 Feb; 26(2):343-51. PubMed ID: 24269383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MSK1 activity is controlled by multiple phosphorylation sites.
    McCoy CE; Campbell DG; Deak M; Bloomberg GB; Arthur JS
    Biochem J; 2005 Apr; 387(Pt 2):507-17. PubMed ID: 15568999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein: MODULATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALING CASCADE IN A CALCIUM-DEPENDENT WAY.
    Gógl G; Alexa A; Kiss B; Katona G; Kovács M; Bodor A; Reményi A; Nyitray L
    J Biol Chem; 2016 Jan; 291(1):11-27. PubMed ID: 26527685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of protein kinase A activity by p90 ribosomal S6 kinase 1.
    Gao X; Patel TB
    J Biol Chem; 2009 Nov; 284(48):33070-8. PubMed ID: 19808666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for activation of the autoinhibitory C-terminal kinase domain of p90 RSK2.
    Malakhova M; Tereshko V; Lee SY; Yao K; Cho YY; Bode A; Dong Z
    Nat Struct Mol Biol; 2008 Jan; 15(1):112-3. PubMed ID: 18084304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial heat shock protein-60 increases epithelial cell proliferation through the ERK1/2 MAP kinases.
    Zhang L; Pelech SL; Mayrand D; Grenier D; Heino J; Uitto VJ
    Exp Cell Res; 2001 May; 266(1):11-20. PubMed ID: 11339820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural assembly of the signaling competent ERK2-RSK1 heterodimeric protein kinase complex.
    Alexa A; Gógl G; Glatz G; Garai Á; Zeke A; Varga J; Dudás E; Jeszenői N; Bodor A; Hetényi C; Reményi A
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2711-6. PubMed ID: 25730857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Basis and Biophysical Approaches to Characterize the C-Terminal Domain of Human-Ribosomal S6 Kinases-3.
    Jagilinki BP; Choudhary RK; Thapa PS; Gadewal N; Hosur MV; Kumar S; Varma AK
    Cell Biochem Biophys; 2016 Sep; 74(3):317-25. PubMed ID: 27324042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive inhibition of MAP kinase activation by a peptide representing the alpha C helix of ERK.
    Horiuchi KY; Scherle PA; Trzaskos JM; Copeland RA
    Biochemistry; 1998 Jun; 37(25):8879-85. PubMed ID: 9636029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RSK family of kinases: emerging roles in cellular signalling.
    Anjum R; Blenis J
    Nat Rev Mol Cell Biol; 2008 Oct; 9(10):747-58. PubMed ID: 18813292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway.
    Péqueux C; Keegan BP; Hagelstein MT; Geenen V; Legros JJ; North WG
    Endocr Relat Cancer; 2004 Dec; 11(4):871-85. PubMed ID: 15613460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.